LeonaBio, Inc.
LONA
DELAYED 1 MONTH

8 insider filings · Latest: May 5, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 4, 2026Mar 6 12:14 AMMark James LittonDirector, PRESIDENT and CEO
Sale
5,156$5.37$27.7K57,926(D)

View →

Mar 4, 2026Mar 6 12:10 AMRobert RenningerCHIEF FINANCIAL OFFICER
Sale
906$5.37$4.9K15,851(D)

View →

Mar 4, 2026Mar 6 12:06 AMMark WorthingtonGENERAL COUNSEL and CCO
Sale
1,328$5.37$7.1K18,376(D)

View →

Mar 4, 2026Mar 6 12:02 AMKevin ChurchCHIEF SCIENTIFIC OFFICER
Sale
1,359$5.37$7.3K25,178(D)

View →

Mar 4, 2026Mar 5 11:59 PMMartin Javier SanCHIEF MEDICAL OFFICER
Sale
1,720$5.37$9.2K15,887(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 5, 2026May 8 12:27 AMNatalie C. HollesDirector
Grant/Award
56,000$9.6356,000(D)

View →

May 5, 2026May 8 12:26 AMPeter B. SilvermanDirector
Grant/Award
56,000$9.6356,000(D)

View →

May 5, 2026May 8 12:24 AMFred CalloriDirector
Grant/Award
56,000$9.6356,000(D)

View →

Mar 3, 2026Mar 6 12:14 AMMark James LittonDirector, PRESIDENT and CEO
Option Exercise
22,254—0(D)

View →

Mar 3, 2026Mar 6 12:10 AMRobert RenningerCHIEF FINANCIAL OFFICER
Option Exercise
3,900—0(D)

View →

Mar 3, 2026Mar 6 12:06 AMMark WorthingtonGENERAL COUNSEL and CCO
Option Exercise
5,726—0(D)

View →

Mar 3, 2026Mar 6 12:02 AMKevin ChurchCHIEF SCIENTIFIC OFFICER
Option Exercise
5,856—0(D)

View →

Mar 3, 2026Mar 5 11:59 PMMartin Javier SanCHIEF MEDICAL OFFICER
Option Exercise
7,418—0(D)

View →